| Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer V Noronha, VM Patil, A Joshi, N Menon, A Chougule, A Mahajan, A Janu, ... Journal of Clinical Oncology 38 (2), 124-136, 2020 | 369 | 2020 |
| Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial V Noronha, A Joshi, VM Patil, J Agarwal, S Ghosh-Laskar, A Budrukkar, ... Journal of Clinical Oncology 36 (11), 1064-1072, 2018 | 318 | 2018 |
| Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trial V Murthy, P Maitre, S Kannan, G Panigrahi, R Krishnatry, G Bakshi, ... Journal of Clinical Oncology 39 (11), 1234-1242, 2021 | 229 | 2021 |
| Primary non-Hodgkin's lymphoma of the liver V Noronha, NQ Shafi, JA Obando, S Kummar Critical reviews in oncology/hematology 53 (3), 199-207, 2005 | 229 | 2005 |
| Crizotinib: A comprehensive review A Sahu, K Prabhash, V Noronha, A Joshi, S Desai South Asian journal of cancer 2 (2), 91, 2013 | 203 | 2013 |
| Epidemiology of lung cancer in India: focus on the differences between non-smokers and smokers: a single-centre experience V Noronha, R Dikshit, N Raut, A Joshi, CS Pramesh, K George, ... Indian journal of cancer 49 (1), 74-81, 2012 | 186 | 2012 |
| Weekly low‐dose versus three‐weekly high‐dose cisplatin for concurrent chemoradiation in locoregionally advanced non‐nasopharyngeal head and neck cancer: a systematic review … P Szturz, K Wouters, N Kiyota, M Tahara, K Prabhash, V Noronha, ... The oncologist 22 (9), 1056-1066, 2017 | 177 | 2017 |
| Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers VM Patil, K Prabhash, V Noronha, A Joshi, V Muddu, S Dhumal, S Arya, ... Oral oncology 50 (10), 1000-1004, 2014 | 145 | 2014 |
| Actionable activating oncogenic ERBB2/HER2 transmembrane and juxtamembrane domain mutations KB Pahuja, TT Nguyen, BS Jaiswal, K Prabhash, TM Thaker, K Senger, ... Cancer cell 34 (5), 792-806. e5, 2018 | 123 | 2018 |
| Lung cancer in the Indian subcontinent V Noronha, R Pinninti, VM Patil, A Joshi, K Prabhash South Asian journal of cancer 5 (03), 095-103, 2016 | 115 | 2016 |
| Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity A Chougule, K Prabhash, V Noronha, A Joshi, A Thavamani, P Chandrani, ... PloS one 8 (10), e76164, 2013 | 115 | 2013 |
| Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern. K Prabhash, A Medhekar, N Ghadyalpatil, V Noronha, S Biswas, ... Indian journal of cancer 47 (2), 2010 | 104 | 2010 |
| Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update W Dale, HD Klepin, GR Williams, SMH Alibhai, C Bergerot, ... Journal of Clinical Oncology 41 (26), 4293-4312, 2023 | 103 | 2023 |
| A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer VM Patil, V Noronha, A Joshi, J Agarwal, S Ghosh‐Laskar, A Budrukkar, ... Cancer 125 (18), 3184-3197, 2019 | 102 | 2019 |
| Low-dose vs. high-dose cisplatin: lessons learned from 59 chemoradiotherapy trials in head and neck cancer P Szturz, K Wouters, N Kiyota, M Tahara, K Prabhash, V Noronha, ... Frontiers in oncology 9, 86, 2019 | 93 | 2019 |
| A fresh look at oncology facts on south central Asia and SAARC countries V Noronha, U Tsomo, A Jamshed, MA Hai, S Wattegama, RP Baral, ... South Asian journal of cancer 1 (01), 01-04, 2012 | 92 | 2012 |
| Low-dose immunotherapy in head and neck cancer: a randomized study VM Patil, V Noronha, N Menon, R Rai, A Bhattacharjee, A Singh, ... Journal of Clinical Oncology 41 (2), 222-232, 2023 | 86 | 2023 |
| A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable … VM Patil, V Noronha, A Joshi, VK Muddu, S Dhumal, B Bhosale, S Arya, ... Oral oncology 51 (3), 279-286, 2015 | 84 | 2015 |
| EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy V Noronha, K Prabhash, A Thavamani, A Chougule, N Purandare, A Joshi, ... PLoS One 8 (4), e61561, 2013 | 81 | 2013 |
| Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group … V Patil, V Noronha, SB Dhumal, A Joshi, N Menon, A Bhattacharjee, ... The Lancet Global Health 8 (9), e1213-e1222, 2020 | 74 | 2020 |
